NPPA notified regarding the computation of the retail price of Olmesartan Medoxomil IP 40 mg + Amlodipine Besilate IP Eq. to Amlodipine 5 mg + Hydrochlorothiazide IP 12.5 mg for M/s Windlas Biotech Limited (Manufacturer) & M/s Alkem Wellness Limited (Marketer)

Mar 10, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Complianceclass="MsoNormal">The National Pharmaceutical Pricing Authority (NPPA) on March 06, 2026, notified regarding the computation of the retail price of Olmesartan Medoxomil IP 40 mg + Amlodipine Besilate IP Eq. to Amlodipine 5 mg + Hydrochlorothiazide IP 12.5 mg for M/s Windlas Biotech Limited (Manufacturer) & M/s Alkem Wellness Limited (Marketer).

It states that the price of each film-coated tablet containing:- Olmesartan Medoxomil IP 40 mg + Amlodipine Besilate IP Eq. to Amlodipine 5 mg + Hydrochlorothiazide IP 12.5 mg for M/s Windlas Biotech Limited (Manufacturer) & M/s Alkem Wellness Limited (Marketer) has been revised to Rs. 21.29/-.

 

[Notification no: 19(5012)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT